Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated Intermediate or High Grade Non-Hodgkin's Lymphoma

NCT00005959 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00005959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated Intermediate or High Grade Non-Hodgkin's Lymphoma
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 1999
Completion date
Not reported
Enrollment
Not reported
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma